A Phase 2a Study of the Early Bactericidal Activity of Rifampicin in Combination With Meropenem Plus Amoxicillin/Clavulanate Among Adults With Rifampicin-Resistant Pulmonary Tuberculosis

Journal:

Clinical Infectious Diseases

Published:

2025-06-02

DOI:

10.1093/cid/ciaf276

Affiliations:

6

Authors:

13

Go to article

Institutions	Authors	Share
TASK, South Africa	5.000000	0.38
Uppsala University (UU), Sweden	3.000000	0.23
Johns Hopkins University (JHU), United States of America (USA)	3.000000	0.23
Medical University of South Carolina (MUSC), United States of America (USA)	1.000000	0.08
Vanderbilt University Medical Center (VUMC), United States of America (USA)	1.000000	0.08

Interested in Pharmacology and Pharmaceutical Sciences?